These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10329016

  • 21. Expression of avian glypican is developmentally regulated.
    Niu S, Antin PB, Akimoto K, Morkin E.
    Dev Dyn; 1996 Sep; 207(1):25-34. PubMed ID: 8875073
    [Abstract] [Full Text] [Related]

  • 22. Analysis of exon/intron structure and 400 kb of genomic sequence surrounding the 5'-promoter and 3'-terminal ends of the human glypican 3 (GPC3) gene.
    Huber R, Crisponi L, Mazzarella R, Chen CN, Su Y, Shizuya H, Chen EY, Cao A, Pilia G.
    Genomics; 1997 Oct 01; 45(1):48-58. PubMed ID: 9339360
    [Abstract] [Full Text] [Related]

  • 23. Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent.
    Litwack ED, Ivins JK, Kumbasar A, Paine-Saunders S, Stipp CS, Lander AD.
    Dev Dyn; 1998 Jan 01; 211(1):72-87. PubMed ID: 9438425
    [Abstract] [Full Text] [Related]

  • 24. An interstitial duplication of chromosome 13q31.3q32.1 further delineates the critical region for postaxial polydactyly type A2.
    van der Zwaag PA, Dijkhuizen T, Gerssen-Schoorl KB, Colijn AW, Broens PM, Flapper BC, van Ravenswaaij-Arts CM.
    Eur J Med Genet; 2010 Jan 01; 53(1):45-9. PubMed ID: 19941983
    [Abstract] [Full Text] [Related]

  • 25. Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling.
    Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A.
    Dev Biol; 2002 Mar 01; 243(1):185-206. PubMed ID: 11846487
    [Abstract] [Full Text] [Related]

  • 26. Regulatory variation at glypican-3 underlies a major growth QTL in mice.
    Oliver F, Christians JK, Liu X, Rhind S, Verma V, Davison C, Brown SD, Denny P, Keightley PD.
    PLoS Biol; 2005 May 01; 3(5):e135. PubMed ID: 15799711
    [Abstract] [Full Text] [Related]

  • 27. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD, Korc M.
    Cancer Res; 2001 Jul 15; 61(14):5562-9. PubMed ID: 11454708
    [Abstract] [Full Text] [Related]

  • 28. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome.
    Cano-Gauci DF, Song HH, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum ND, Filmus J.
    J Cell Biol; 1999 Jul 12; 146(1):255-64. PubMed ID: 10402475
    [Abstract] [Full Text] [Related]

  • 29. Cardiac anomalies in the Simpson-Golabi-Behmel syndrome.
    Lin AE, Neri G, Hughes-Benzie R, Weksberg R.
    Am J Med Genet; 1999 Apr 23; 83(5):378-81. PubMed ID: 10232747
    [Abstract] [Full Text] [Related]

  • 30. Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.
    Lindsay S, Ireland M, O'Brien O, Clayton-Smith J, Hurst JA, Mann J, Cole T, Sampson J, Slaney S, Schlessinger D, Burn J, Pilia G.
    J Med Genet; 1997 Jun 23; 34(6):480-3. PubMed ID: 9192268
    [Abstract] [Full Text] [Related]

  • 31. Multiple Sp1 sites efficiently drive transcription of the TATA-less promoter of the human glypican 3 (GPC3) gene.
    Huber R, Schlessinger D, Pilia G.
    Gene; 1998 Jul 03; 214(1-2):35-44. PubMed ID: 9651473
    [Abstract] [Full Text] [Related]

  • 32. K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney.
    Watanabe K, Yamada H, Yamaguchi Y.
    J Cell Biol; 1995 Sep 03; 130(5):1207-18. PubMed ID: 7657705
    [Abstract] [Full Text] [Related]

  • 33. Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.
    Shen T, Sonoda G, Hamid J, Li M, Filmus J, Buick RN, Testa JR.
    Mamm Genome; 1997 Jan 03; 8(1):72. PubMed ID: 9021160
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Selection of a high activity ribozyme against cytostatic drug resistance-associated glypican-3 using an in vitro assay containing total tumor RNA.
    Wichert A, Holm PS, Dietel M, Lage H.
    Cancer Gene Ther; 1999 Jan 03; 6(3):263-70. PubMed ID: 10359212
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.